Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last C$0.07 CAD
Change Today -0.005 / -7.14%
Volume 567.0K
ICO On Other Exchanges
As of 3:48 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Andrew J. Rae BSc, MBA

Co-Founder, Chief Executive Officer, President, Director, Chairman of Governance & Nominating Committee, Member of Audit Committee and Member of Compensation Committee, iCo Therapeutics Inc.
AgeTotal Calculated CompensationThis person is connected to 15 board members in 1 different organizations across 4 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Andrew J. Rae, BSc, MBA, co-founded ICo Therapeutics Inc. in 2005 and serves as its Chief Executive Officer and President since February 2005. Mr. Rae serves as a Consultant to Ventures West Management. He has a decade of experience in the biotechnology field. Mr. Rae served as the Chief Financial Officer of Ability Biomedical Corp. of Irvine, California and Vancouver, British Columbia and as its Chief Executive Officer since February 2005. He served as Vice-President ...

Read Full Background

Corporate Headquarters*

760-777 Hornby Street
Vancouver, British Columbia V6Z 1S4


Phone: 604-602-9414
Fax: 604-602-9699

Board Members Memberships*

Co-Founder, Chief Executive Officer, President, Director, Chairman of Governance & Nominating Committee, Member of Audit Committee and Member of Compensation Committee


The University Of Western Ontario
Simon Fraser University

Other Affiliations*

Annual Compensation*

Total Annual CompensationC$312,000

Stock Options*

All Other CompensationC$3,977
Total Number of Options650,000

Total Compensation*

Total Annual Cash CompensationC$315,977
Total Short Term CompensationC$312,000
Other Long Term CompensationC$3,977
Total Calculated CompensationC$315,977
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ICO:CN C$0.07 CAD -0.005


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ICO THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at